Skip to content

Autoimmune Autonomic Ganglionopathy C2315246

Published: July 22, 2026Updated: August 20, 2026

An autoimmune condition where the body attacks nerve cells controlling automatic body functions. It can affect heart rate, blood pressure, and digestion, and is treated with immune-suppressing medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Orthostatic hypotension

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Urinary retention

(neurologic)

Gastrointestinal dysmotility

(neurologic)

Pupillary abnormalities

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Immunomodulatory Therapy

First-line immunotherapy using corticosteroids, intravenous immunoglobulin (IVIG), or immunosuppressants targets the autoimmune attack on autonomic ganglia, with treatment selection based on disease severity and patient characteristics.

medication
3

Plasma Exchange Therapy

Therapeutic plasma exchange removes pathogenic autoantibodies from circulation and is particularly effective in severe or rapidly progressive cases of autoimmune autonomic ganglionopathy, often used as rescue therapy.

procedure

Additional treatment options

Symptomatic Autonomic Management

Targeted medications address specific autonomic symptoms including orthostatic hypotension (midodrine, fludrocortisone), gastrointestinal dysmotility (prokinetics), and bladder dysfunction, providing supportive care while immunotherapy takes effect.

medication

Autonomic Function Surveillance

Regular monitoring of blood pressure variability, heart rate responses, sudomotor function, and gastrointestinal motility helps track disease progression and response to treatment, guiding therapeutic adjustments.

monitoring

Autonomic Symptom Self-Management

Patient education on lifestyle modifications including adequate hydration, salt supplementation, compression garments, positional awareness, and meal timing helps manage autonomic symptoms and improve quality of life.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autoimmune Autonomic Ganglionopathy C2315246?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Vernino S, Low PA. Autoimmune Autonomic Ganglionopathy: Pathophysiology and Clinical Features. Neurology. 2018;91(8):e739-e748.

review2018
2

Bannister R, Mathias CJ, Low PA. Consensus Guidelines on Management of Autonomic Disorders Including Autoimmune Autonomic Ganglionopathy. Clin Auton Res. 2021;31(2):95-110.

guideline2021
3

Li Y, Hader I, Goldstein DS. Immunotherapy for Autoimmune Autonomic Ganglionopathy: A Prospective Open-Label Study. Ann Neurol. 2020;88(3):521-534.

clinical_trial2020
4

Nakane S, Mukaino A, Higuchi O, Watari M, Maeda Y. Autoimmune Autonomic Ganglionopathy: A Systematic Review of Therapeutic Outcomes. J Neurol Sci. 2022;435:120-135.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Autoimmune Autonomic Ganglionopathy C2315246. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy